Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

leucovorin

leucovorin
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Leucovorin Calcium POWDER FOR INJECTION, INJECTABLE 50 mg, 100 mg, 200 mg, 350 mg      
Wellcovorin TABLET, ORAL 5 mg, 25 mg      


Comments:

Note: This chart does not supersede clinical judgment.

If SCr is increased >50% above baseline, increase the standard leucovorin dose to 100 mg/m2 IV every 3 hours, then adjust according to methotrexate levels.

 

Methotrexate level at 24 to 35 hours:

Methotrexate Level (µM/L)

Leucovorin dosing

>100

1,000 mg/m2 IV every 6 hours

>10 to <100

100 mg/m2 IV every 3 hours

~1 to 10

10 mg/m2 IV 6 hours

 

Methotrexate level at 36 to 71 hours:

Methotrexate Level (µM/L)

Leucovorin dosing

>100

1,000 mg/m2 IV every 6 hours

>10 to <100

100 mg/m2 IV every 3 hours

~1 to 10

100 mg/m2 IV every 6 hours

 

Methotrexate level at 72+ hours:

Methotrexate Level (µM/L)

Leucovorin dosing

>10

100 to 1,000 mg/m2 IV every 3 hours

~1 to 10

10 mg/m2 to 100 mg/m2 IV every 3 hours

~0.1 to 1

10 mg/m2 IV every 6 hours

 

Generally, leucovorin can be discontinued when methotrexate levels are < 0.1.


Last updated: Dec. 22, 2023
  • Formulary, Not Routinely Stocked: 25 mg tablet







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.